NASDAQ:ULBI

Ultralife Competitors

$8.43
-0.04 (-0.47 %)
(As of 04/16/2021 12:00 AM ET)
Add
Compare
Today's Range
$8.30
Now: $8.43
$8.51
50-Day Range
$6.65
MA: $7.79
$8.60
52-Week Range
$5.10
Now: $8.43
$9.20
Volume39,779 shs
Average Volume118,581 shs
Market Capitalization$134.84 million
P/E Ratio28.10
Dividend YieldN/A
Beta1.57

Competitors

Ultralife (NASDAQ:ULBI) Vs. CAE, NOVT, SPB, ATKR, ENR, and FCEL

Should you be buying ULBI stock or one of its competitors? Companies in the industry of "miscellaneous electrical machinery, equipment, & supplies" are considered alternatives and competitors to Ultralife, including CAE (CAE), Novanta (NOVT), Spectrum Brands (SPB), Atkore (ATKR), Energizer (ENR), and FuelCell Energy (FCEL).

CAE (NYSE:CAE) and Ultralife (NASDAQ:ULBI) are both aerospace companies, but which is the better investment? We will contrast the two businesses based on the strength of their risk, profitability, valuation, dividends, earnings, institutional ownership and analyst recommendations.

Volatility & Risk

CAE has a beta of 1.73, suggesting that its share price is 73% more volatile than the S&P 500. Comparatively, Ultralife has a beta of 1.57, suggesting that its share price is 57% more volatile than the S&P 500.

Profitability

This table compares CAE and Ultralife's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
CAE2.07%9.35%2.93%
Ultralife4.33%5.36%4.24%

Analyst Recommendations

This is a summary of current ratings for CAE and Ultralife, as reported by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
CAE06502.45
Ultralife00103.00

CAE presently has a consensus target price of $39.25, suggesting a potential upside of 32.02%. Ultralife has a consensus target price of $12.00, suggesting a potential upside of 42.35%. Given Ultralife's stronger consensus rating and higher possible upside, analysts plainly believe Ultralife is more favorable than CAE.

Valuation & Earnings

This table compares CAE and Ultralife's revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
CAE$2.70 billion3.23$234.11 million$1.0029.73
Ultralife$106.79 million1.26$5.20 millionN/AN/A

CAE has higher revenue and earnings than Ultralife.

Institutional & Insider Ownership

52.3% of CAE shares are held by institutional investors. Comparatively, 35.0% of Ultralife shares are held by institutional investors. 18.3% of CAE shares are held by company insiders. Comparatively, 38.4% of Ultralife shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Summary

CAE beats Ultralife on 8 of the 13 factors compared between the two stocks.

Novanta (NASDAQ:NOVT) and Ultralife (NASDAQ:ULBI) are both computer and technology companies, but which is the superior investment? We will contrast the two businesses based on the strength of their earnings, profitability, analyst recommendations, valuation, institutional ownership, dividends and risk.

Institutional & Insider Ownership

90.2% of Novanta shares are owned by institutional investors. Comparatively, 35.0% of Ultralife shares are owned by institutional investors. 3.6% of Novanta shares are owned by company insiders. Comparatively, 38.4% of Ultralife shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Profitability

This table compares Novanta and Ultralife's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Novanta6.81%16.33%8.16%
Ultralife4.33%5.36%4.24%

Analyst Recommendations

This is a summary of recent ratings and recommmendations for Novanta and Ultralife, as provided by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Novanta02002.00
Ultralife00103.00

Novanta currently has a consensus price target of $99.50, indicating a potential downside of 26.66%. Ultralife has a consensus price target of $12.00, indicating a potential upside of 42.35%. Given Ultralife's stronger consensus rating and higher probable upside, analysts clearly believe Ultralife is more favorable than Novanta.

Volatility and Risk

Novanta has a beta of 1.09, suggesting that its stock price is 9% more volatile than the S&P 500. Comparatively, Ultralife has a beta of 1.57, suggesting that its stock price is 57% more volatile than the S&P 500.

Earnings & Valuation

This table compares Novanta and Ultralife's top-line revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Novanta$626.10 million7.67$40.77 million$2.1463.40
Ultralife$106.79 million1.26$5.20 millionN/AN/A

Novanta has higher revenue and earnings than Ultralife.

Summary

Novanta beats Ultralife on 8 of the 13 factors compared between the two stocks.

Ultralife (NASDAQ:ULBI) and Spectrum Brands (NYSE:SPB) are both computer and technology companies, but which is the superior investment? We will contrast the two businesses based on the strength of their earnings, risk, valuation, institutional ownership, profitability, dividends and analyst recommendations.

Earnings & Valuation

This table compares Ultralife and Spectrum Brands' revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Ultralife$106.79 million1.26$5.20 millionN/AN/A
Spectrum Brands$3.96 billion0.96$97.80 million$4.1021.67

Spectrum Brands has higher revenue and earnings than Ultralife.

Analyst Ratings

This is a breakdown of recent recommendations for Ultralife and Spectrum Brands, as reported by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Ultralife00103.00
Spectrum Brands01502.83

Ultralife currently has a consensus target price of $12.00, indicating a potential upside of 42.35%. Spectrum Brands has a consensus target price of $82.50, indicating a potential downside of 7.16%. Given Ultralife's stronger consensus rating and higher probable upside, analysts plainly believe Ultralife is more favorable than Spectrum Brands.

Risk & Volatility

Ultralife has a beta of 1.57, suggesting that its share price is 57% more volatile than the S&P 500. Comparatively, Spectrum Brands has a beta of 1.94, suggesting that its share price is 94% more volatile than the S&P 500.

Profitability

This table compares Ultralife and Spectrum Brands' net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Ultralife4.33%5.36%4.24%
Spectrum Brands2.46%13.35%3.59%

Insider and Institutional Ownership

35.0% of Ultralife shares are held by institutional investors. Comparatively, 92.6% of Spectrum Brands shares are held by institutional investors. 38.4% of Ultralife shares are held by insiders. Comparatively, 2.2% of Spectrum Brands shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Summary

Spectrum Brands beats Ultralife on 7 of the 13 factors compared between the two stocks.

Atkore (NYSE:ATKR) and Ultralife (NASDAQ:ULBI) are both industrial products companies, but which is the superior investment? We will compare the two businesses based on the strength of their dividends, risk, analyst recommendations, earnings, valuation, profitability and institutional ownership.

Profitability

This table compares Atkore and Ultralife's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Atkore8.63%47.96%10.08%
Ultralife4.33%5.36%4.24%

Risk and Volatility

Atkore has a beta of 2.47, indicating that its stock price is 147% more volatile than the S&P 500. Comparatively, Ultralife has a beta of 1.57, indicating that its stock price is 57% more volatile than the S&P 500.

Valuation & Earnings

This table compares Atkore and Ultralife's gross revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Atkore$1.77 billion1.93$152.30 millionN/AN/A
Ultralife$106.79 million1.26$5.20 millionN/AN/A

Atkore has higher revenue and earnings than Ultralife.

Institutional and Insider Ownership

97.4% of Atkore shares are owned by institutional investors. Comparatively, 35.0% of Ultralife shares are owned by institutional investors. 1.7% of Atkore shares are owned by insiders. Comparatively, 38.4% of Ultralife shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Analyst Recommendations

This is a breakdown of current ratings and recommmendations for Atkore and Ultralife, as reported by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Atkore01302.75
Ultralife00103.00

Atkore currently has a consensus target price of $61.00, suggesting a potential downside of 16.32%. Ultralife has a consensus target price of $12.00, suggesting a potential upside of 42.35%. Given Ultralife's stronger consensus rating and higher possible upside, analysts clearly believe Ultralife is more favorable than Atkore.

Summary

Atkore beats Ultralife on 9 of the 13 factors compared between the two stocks.

Energizer (NYSE:ENR) and Ultralife (NASDAQ:ULBI) are both consumer staples companies, but which is the superior investment? We will contrast the two businesses based on the strength of their risk, profitability, institutional ownership, earnings, valuation, dividends and analyst recommendations.

Institutional & Insider Ownership

86.4% of Energizer shares are held by institutional investors. Comparatively, 35.0% of Ultralife shares are held by institutional investors. 1.4% of Energizer shares are held by company insiders. Comparatively, 38.4% of Ultralife shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Volatility and Risk

Energizer has a beta of 1.17, suggesting that its share price is 17% more volatile than the S&P 500. Comparatively, Ultralife has a beta of 1.57, suggesting that its share price is 57% more volatile than the S&P 500.

Profitability

This table compares Energizer and Ultralife's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Energizer-3.40%42.70%3.34%
Ultralife4.33%5.36%4.24%

Earnings and Valuation

This table compares Energizer and Ultralife's top-line revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Energizer$2.74 billion1.24$-93,300,000.00$2.3121.50
Ultralife$106.79 million1.26$5.20 millionN/AN/A

Ultralife has lower revenue, but higher earnings than Energizer.

Analyst Recommendations

This is a summary of recent ratings and price targets for Energizer and Ultralife, as provided by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Energizer04802.67
Ultralife00103.00

Energizer currently has a consensus price target of $50.6667, suggesting a potential upside of 2.01%. Ultralife has a consensus price target of $12.00, suggesting a potential upside of 42.35%. Given Ultralife's stronger consensus rating and higher probable upside, analysts clearly believe Ultralife is more favorable than Energizer.

Summary

Ultralife beats Energizer on 9 of the 13 factors compared between the two stocks.

FuelCell Energy (NASDAQ:FCEL) and Ultralife (NASDAQ:ULBI) are both oils/energy companies, but which is the better business? We will compare the two businesses based on the strength of their risk, analyst recommendations, earnings, dividends, profitability, institutional ownership and valuation.

Insider & Institutional Ownership

33.7% of FuelCell Energy shares are owned by institutional investors. Comparatively, 35.0% of Ultralife shares are owned by institutional investors. 0.1% of FuelCell Energy shares are owned by insiders. Comparatively, 38.4% of Ultralife shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Earnings and Valuation

This table compares FuelCell Energy and Ultralife's gross revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
FuelCell Energy$60.75 million52.33$-77,570,000.00($1.30)-7.58
Ultralife$106.79 million1.26$5.20 millionN/AN/A

Ultralife has higher revenue and earnings than FuelCell Energy.

Volatility and Risk

FuelCell Energy has a beta of 5.33, suggesting that its share price is 433% more volatile than the S&P 500. Comparatively, Ultralife has a beta of 1.57, suggesting that its share price is 57% more volatile than the S&P 500.

Profitability

This table compares FuelCell Energy and Ultralife's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
FuelCell Energy-162.42%-74.92%-13.77%
Ultralife4.33%5.36%4.24%

Analyst Ratings

This is a summary of recent recommendations and price targets for FuelCell Energy and Ultralife, as provided by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
FuelCell Energy25001.71
Ultralife00103.00

FuelCell Energy currently has a consensus price target of $9.1250, indicating a potential downside of 7.45%. Ultralife has a consensus price target of $12.00, indicating a potential upside of 42.35%. Given Ultralife's stronger consensus rating and higher possible upside, analysts plainly believe Ultralife is more favorable than FuelCell Energy.

Summary

Ultralife beats FuelCell Energy on 11 of the 13 factors compared between the two stocks.


Ultralife Competitors List

Competitor NameCompetitor BTM RankCompetitor PriceCompetitor Price ChangeCompetitor Market CapCompetitor RevenueCompetitor P/E RatioCompetitor Indicator(s)
CAE logo
CAE
CAE
1.9$29.73-1.1%$8.72 billion$2.70 billion165.18Analyst Report
Novanta logo
NOVT
Novanta
1.5$135.67-0.3%$4.80 billion$626.10 million116.96News Coverage
Spectrum Brands logo
SPB
Spectrum Brands
2.3$88.86-1.1%$3.79 billion$3.96 billion37.03
Atkore logo
ATKR
Atkore
1.4$72.90-0.2%$3.40 billion$1.77 billion23.44Decrease in Short Interest
Energizer logo
ENR
Energizer
2.4$49.67-0.4%$3.40 billion$2.74 billion-31.44Analyst Report
News Coverage
FuelCell Energy logo
FCEL
FuelCell Energy
0.8$9.86-2.0%$3.18 billion$60.75 million-17.30Analyst Report
Analyst Revision
Integer logo
ITGR
Integer
1.6$93.05-0.6%$3.07 billion$1.26 billion42.30
Eos Energy Enterprises logo
EOSE
Eos Energy Enterprises
1.5$14.34-2.8%$742.83 millionN/A0.00Increase in Short Interest
News Coverage
CBAT
CBAK Energy Technology
0.5$4.46-2.2%$392.95 million$22.19 million-29.73Gap Up
Romeo Power logo
RMO
Romeo Power
1.6$8.37-0.5%$240.64 millionN/A0.00Analyst Downgrade
Increase in Short Interest
News Coverage
Flux Power logo
FLUX
Flux Power
1.5$11.08-2.2%$140.76 million$16.84 million-4.47Analyst Upgrade
Increase in Short Interest
Polar Power logo
POLA
Polar Power
0.7$10.21-0.9%$130.57 million$24.80 million0.00Gap Up
This page was last updated on 4/18/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.